Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Artemis Diagnostics awarded two grants from Technology Strategy Board to develop cancer imaging technology

December 7, 2012 1:40 pm | by Bio-Medicine.Org | News | Comments

HERTFORDSHIRE, United Kingdom, Dec. 7, 2012 /PRNewswire-iReach/ -- Artemis Diagnostics, a developer of innovative imaging technologies for cancer surgery, announced today that the company has been awarded two Smart grants from the Technology Strategy Board, the UK's innovation agency. The two grants, totaling more than £120,000 (US$ 193,000), provide funding for the company to develop its i...

NeuroPace's epilepsy implant lands a date with the FDA after more than 2 years

December 7, 2012 1:22 pm | by Mass Device | News | Comments

More than 2 years after submitting its original premarket approval application, California device maker NeuroPace lands an FDA panel meeting to review its epilepsy-treating neuromodulation implant. California medical device maker NeuroPace is finally getting a date with the FDA to review its premarket application...

Greatbatch Promotes Bratton to President of Electrochem Solutions, Inc.

December 7, 2012 1:00 pm | by The Associated Press | News | Comments

FRISCO, Texas--(BUSINESS WIRE)--Dec 7, 2012--Greatbatch, Inc (NYSE:GB), today announced it has promoted Susan M. Bratton to the position of president of its subsidiary Electrochem Solutions, Inc. Mrs. Bratton previously held the position of senior vice president at Electrochem and will maintain...

Advertisement

Abiomed shares sink as FDA votes to keep Impella pump at highest risk level

December 7, 2012 12:40 pm | by Mass Device | News | Comments

The FDA's Circulatory System Devices Panel votes to keep Abiomed's Impella heart pump at a Class III risk level, meaning the devices will continue to pass through the premarket review process. Abiomed (NSDQ:ABMD) shares slid 7% on Wall Street after the Danvers, Mass.-based cardiac devices maker lost a bid to have its star Impella heart pumps shifted to a lower FDA review risk category.

New Study Shows Zylast Antiseptic Products Kill More than 99.99% of E. Coli, Other Bacteria, on Contact

December 7, 2012 12:31 pm | by Bio-Medicine.Org | News | Comments

TARRYTOWN, N.Y., Dec. 7, 2012 /- Innovative BioDefense Inc, the creators of the Zylast® line of antimicrobial products, announced today that a new round of extensive time-kill testing on the Zylast products showed that more than 99.99 percent of disease-causing germs were destroyed within 15 seconds, making Zylast the most effective antimicrobial on the market.  The Z...

Research and Markets: Analysis of Nucleic Acid Testing Technologies And Strategic Profiles of Leading Suppliers

December 7, 2012 11:57 am | by The Associated Press | News | Comments

DUBLIN--(BUSINESS WIRE)--Dec 7, 2012--Research and Markets ( http://www.researchandmarkets.com/research/w93wbw/analysis_of ) has announced the addition of the "Analysis of Nucleic Acid Testing Technologies And Strategic Profiles of Leading Suppliers" report to their offering. This 180-page report...

Research and Markets: Analysis of Emerging Nucleic Acid Testing Assays And Strategic Profiles of Leading Suppliers

December 7, 2012 11:54 am | by The Associated Press | News | Comments

DUBLIN--(BUSINESS WIRE)--Dec 7, 2012--Research and Markets ( http://www.researchandmarkets.com/research/63j9tv/analysis_of ) has announced the addition of the "Analysis of Emerging Nucleic Acid Testing Assays And Strategic Profiles of Leading Suppliers" report to their offering. This 549-page...

Research and Markets: Analysis of Transfusion Diagnostic Typing, Grouping and Screening Tests, And Strategic Profiles and Leading Suppliers

December 7, 2012 11:50 am | by The Associated Press | News | Comments

DUBLIN--(BUSINESS WIRE)--Dec 7, 2012--Research and Markets ( http://www.researchandmarkets.com/research/5fx9v7/analysis_of ) has announced the addition of the "Analysis of Transfusion Diagnostic Typing, Grouping and Screening Tests, And Strategic Profiles and Leading Suppliers" report to their...

Advertisement

Gore lands CE Mark for its next-gen endoprosthesis

December 7, 2012 10:23 am | by Mass Device | News | Comments

W.L. Gore & Associates wins CE Mark approval for its next- generation Excluder AAA endoprosthesis, featuring large diameter 35 mm trunk-ipsilateral legs and 36 mm aortic extender components. The device is an endovascular stent-graft, designed to be inserted through a small incision in the patient's leg...

Obesity and Overeating During Menopause Together Promote Breast Tumor Growth and Progression

December 7, 2012 10:00 am | by AACR | News | Comments

In a rat model, premenopausal obesity impaired ability to handle postmenopausal overeating. Obese animals’ tumors expressed more markers of increased energy use and proliferation. Results have implications for weight and metabolic control in perimenopausal women. PHILADELPHIA — Obese women might be able to eliminate their increased risk for postmenopausal breast cancer by taking measures during [...]

Photo-Etched EMI/RFI Shielding Components

December 7, 2012 9:41 am | Stork Veco B.V. | Product Releases | Comments

Custom manufactured metallic EMI/RFI shielding components for integration into printed circuit boards and other electronic devices are being introduced by Stork-Veco International.

FzioMed files citizen petition for reconsideration following FDA rejection of its spinal gel PMA

December 7, 2012 9:36 am | by Mass Device | News | Comments

Privately held medical device maker FzioMed urges the FDA commissioner to reconsider its premarket approval bid for the Oxiplex spinal gel after the application was rejected by the federal watchdog agency. California device maker FzioMed filed a citizen's petition with the commissioner of the FDA, asking the agency to re-open a rejected premarket approval application for its Oxiplex spinal surgery gel.

Single Output 60W AC-DC Power Supply

December 7, 2012 9:36 am | Power Sources Unlimited Inc. | Product Releases | Comments

Power Sources Unlimited, Inc. announces the new and improved GRN-60 series of "green" power supplies featuring input protection dual fusing for line and neutral leads (-DF models).

Research and Markets: Medical Device Market Opportunities In France, 2012

December 7, 2012 9:35 am | by The Associated Press | News | Comments

DUBLIN--(BUSINESS WIRE)--Dec 7, 2012--Research and Markets ( http://www.researchandmarkets.com/research/ff8lql/medical_device ) has announced the addition of the "Medical Device Market Opportunities In France, 2012" report to their offering. Medical Device Market Opportunities in France, 2012...

IDE-Based Software Development Tool

December 7, 2012 9:33 am | Mouser Electronics, Inc. | Product Releases | Comments

Mouser Electronics, Inc. is stocking and shipping the NXP Semiconductors’ LPC800 LPCXpresso Board, based on the new 32-bit LPC800 microcontroller family designed for the 8-bit microcontroller market.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading